Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
FOXO4-DRI Human Trials: Status, Evidence Gaps, and What to Watch (2026) As of July 2026, no human trial of FOXO4-DRI has ever been registered or published
Target-based drug discovery has become the primary approach in pharmaceutical research and development, where drug targets play a crucial role in guiding the entire process
How it transforms your skin: Visibly fades dark spots, post-acne marks, and sun-induced pigmentation
Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency
US$ 25.91
US$ 26.91
US$ 22.41
US$ 28.74
US$ 24.59
US$ 23.75
